Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT04138719

Recruiting

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Breast Cancer | Triple-negative Breast Cancer | Nab-paclitaxel
NCT02448771

Completed

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Breast Cancer Stage IV | Unresectable Locally Advanced Invasive Breast Cancer | Metastatic Invasive Breast Cancer
NCT01091454

Completed

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Triple-negative Breast Cancer
NCT00369655

Completed

VEGF Trap in Treating Patients With Metastatic Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
NCT02954874

Active, not recruiting

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Breast Carcinoma In Situ | Invasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7
NCT07593651

Not yet recruiting

EXpander-based Versus Direct to Implant PRE-pectoral Breast Reconstruction: a Comparative Analysis of Surgical Outcomes (EXPRESSO)

Breast Cancer | Operable Breast Cancer
NCT07389967

Recruiting

Nutrition Awareness Among Women With Non-Metastatic Breast Cancer

Breast Cancer | Breast Cancer Metastatic
NCT06264934

Recruiting

An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical Capacitance Tomography Scanner (DiCECT)

Breast Cancer | Benign Breast Disease
NCT07475325

Active, not recruiting

Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France. (E-C-HAU)

Breast Cancer | Invasive Breast Carcinoma
NCT03012399

Active, not recruiting

Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage IA Breast Cancer AJCC v8 | Prognostic Stage IB Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Prognostic Stage 0 Breast Cancer AJCC v8
NCT05545150

Active, not recruiting

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

Anatomic Stage 0 Breast Cancer AJCC v8 | Prognostic Stage 0 Breast Cancer AJCC v8 | Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Bilateral Breast Carcinoma
NCT00637481

Completed

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Breast Cancer | Ductal Breast Carcinoma in Situ | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ
NCT07487519

Not yet recruiting

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

Breast Cancer (Triple Negative Breast Cancer (TNBC))
NCT07269691

Not yet recruiting

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT07161791

Not yet recruiting

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

Breast Cancer | Triple Negative Breast Cancer (TNBC)
NCT07053085

Recruiting

A Study of Surgery and Radiotherapy in People With Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT07019337

Not yet recruiting

Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT06677879

Recruiting

A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.

Breast Cancer
NCT06102824

Recruiting

Organoid-based Functional Precision Therapy for Advanced Breast Cancer (ORIENTA)

Advanced Breast Cancer | HER2-negative Breast Cancer
NCT03788083

Recruiting

Intratumoral TriMix Injections in Early Breast Cancer Patients (TMBA)

Breast Cancer Female | Early-stage Breast Cancer
NCT07541703

Active, not recruiting

Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

Breast Cancer | Early Breast Cancer | ER-Positive HER2-Negative Breast Cancer
NCT05963997

Completed

A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer (SUMIT-ELA)

Breast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer
NCT04556773

Active, not recruiting

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer (DB-08)

Metastatic Breast Cancer
NCT03571633

Active, not recruiting

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer (BREASTIMMU02)

HER2-positive Breast Cancer | Operable Breast Cancer
NCT05954143

Terminated

Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT03755141

Completed

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT02595762

Completed

A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Breast Cancer
NCT02965950

Active, not recruiting

The p53 Breast Cancer Trial (p53b)

Locally Advanced Breast Cancer | Metastatic Breast Carcinoma
NCT02462200

Terminated

Shave Margins in Breast Conservation Therapy (SMART)

Breast Cancer | Cancer of Breast | Cancer of the Breast
NCT04298333

Completed

Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer
NCT04095390

Unknown

A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer (INPHASE)

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT03281902

Active, not recruiting

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

Recurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Advanced Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma
NCT02587663

Completed

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

Stage II Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma In Situ
NCT07597642

Not yet recruiting

ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy (ONSET)

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT07227038

Recruiting

Living Well With Advanced Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Breast Carcinoma | Metastatic Breast Carcinoma
NCT06998407

Recruiting

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors (AVZO-023-1001)

HR+/HER2- Breast Cancer | HR+, HER2-, Advanced Breast Cancer
NCT06917313

Recruiting

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06806072

Not yet recruiting

BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06885671

Not yet recruiting

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06733233

Not yet recruiting

A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer

HER2 Low Breast Cancer | Breast Cancer, Estrogen Receptor-Positive
NCT06723990

Recruiting

Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX (HER2BREASTDX)

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06404463

Not yet recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer (QUEEN-Neo)

Neoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
NCT05959291

Recruiting

Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer (Free-HER)

Stage IV Breast Cancer | HER2-positive Metastatic Breast Cancer
NCT05870813

Recruiting

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer (CLEAR-B)

Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer
NCT05774951

Recruiting

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)

Breast Cancer, Early Breast Cancer
NCT05404321

Recruiting

Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment (TRIPLEX)

Triple Negative Breast Cancer | Organoid
NCT05305937

Not yet recruiting

Implantation of CEST and CESL MRI Methods for Detection of Breast Tumors

Malignant Tumor of Breast | Benign Breast Lumps | High-Risk Breast Cancer
NCT04573231

Recruiting

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Breast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer
NCT04505826

Completed

A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer
NCT07030231

Enrolling by invitation

Use of Intraoperative Radiotherapy in Breast Cancer (RIOMA)

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations